P2.03b-012 A Phase II Study of Etirinotecan Pegol (NKTR-102) in Patients with Refractory Brain Metastases and Advanced Lung Cancer

Authors:
  • SNSeema Nagpal
    Seema Nagpal
  • HWHeather Wakelee
    Heather Wakelee
  • SPSukhmani Padda
    Sukhmani Padda
  • SBSophie Bertrand
    Sophie Bertrand
  • BABrenda Acevedo
    Brenda Acevedo
  • ATAlison Holmes Tisch
    Alison Holmes Tisch
  • JPJudy Pagtama
    Judy Pagtama
  • SSScott Soltys
    Scott Soltys
  • JNJoel Neal
    Joel Neal

Abstract
No abstract available